FDA Drug Recalls

Recalls / Class II

Class IID-0908-2023

Product

Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 0113-0847-39), and b) 45-count cartons (NDC 0113-0847-95), Distributed by: Perrigo, Allegan, MI 49010.

Brand name
Good Sense Aller Ease
Generic name
Fexofenadine Hydrochloride
Active ingredient
Fexofenadine Hydrochloride
Route
Oral
NDC
0113-0847
FDA application
ANDA212971
Affected lot / code info
Lot #: a) 2DV1869, 2EV1613, 2EV1614, Exp. date 12/23; 2EV1820, 2FV1943, Exp. date 01/24; 2GV1893, Exp. date 04/24. Lot #: b) 2CR0653, 2DR0466, Exp. date 12/23, 2ER2087, Exp. date 01/24

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
L. Perrigo Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
32,376 cartons
Distribution pattern
Nationwide within the USA

Timeline

Recall initiated
2023-02-09
FDA classified
2023-07-11
Posted by FDA
2023-07-19
Terminated
2023-09-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0908-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.